InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank79
3Y CAGR-77.9%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-77.9%/yr
Quarterly compound
Percentile
P79
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.47% |
| Q3 2025 | -36.97% |
| Q2 2025 | 40.87% |
| Q1 2025 | 13.48% |
| Q4 2024 | -12.09% |
| Q3 2024 | -1.44% |
| Q2 2024 | 9.42% |
| Q1 2024 | -5.45% |
| Q4 2023 | 37.52% |
| Q3 2023 | -70.54% |
| Q2 2023 | 196.11% |
| Q1 2023 | 62.55% |
| Q4 2022 | 43.56% |
| Q3 2022 | -13.93% |
| Q2 2022 | 66.27% |
| Q1 2022 | -7.65% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |